$65.48
+1.60 (+2.50%)
At Close: Jun 03, 2026
Xconomy: Cullinan Oncology Reels In $98M to Advance Cancer Drug Pipeline
08:55pm, Thursday, 04'th Jun 2020
Cullinan Oncology emerged nearly three years ago with an approach to cancer drugs its founders said would improve the odds of success. Now it has a
Naar een globale, economische ontkoppeling?
12:00am, Wednesday, 03'rd Jun 2020
Obligaties Analyses door Oblis over: Boeing Co, Cisco Systems Inc, Deutsche Bank AG, Qualcomm Incorporated. Lees Oblis's Obligaties Analyses op Investing.com.
SAN FRANCISCO, May 29, 2020 -- BridgeBio Pharma, Inc. (Nasdaq: BBIO) affiliate QED Therapeutics announced today that it will present data at the American Society of Clinical.
21 Risky Stocks That Might Have Borrowed More Than Is Good For Them
01:37pm, Tuesday, 19'th May 2020
Monetary and fiscal stimulus has reopened the credit markets even for companies that have seen their businesses get hit hard by coronavirus. That large debt load relative to earnings could cause probl
21 Stocks That Might Have Borrowed More Than Is Good For Them
10:45am, Tuesday, 19'th May 2020
Monetary and fiscal stimulus has reopened the credit markets even for companies that have seen their businesses get hit hard by coronavirus. That large debt load relative to earnings could cause probl
Phoenix Tissue Repair, Inc. (PTR), an affiliate company of BridgeBio Pharma, Inc. (BBIO) today announced updates to its ongoing Phase 1/2 study of PTR-01 (BridgeBio designation BBP-589), an intravenou
BridgeBio Pharma, Inc. Reports First Quarter 2020 Financial Results and Business Update
08:01pm, Wednesday, 13'th May 2020
The company is working with its committed partners to minimize disruption from the COVID-19 pandemic on its clinical trials and other drug development programs. Despite the challenges presented by CO
BridgeBio Pharma, Inc. (BBIO) affiliate QED Therapeutics announced today that in vitro and in vivo data from two studies support QED’s plans to evaluate a low dose of infigratinib as a treatment opt
BridgeBio Pharma, Inc. To Present At Upcoming Investor Conference
08:30pm, Wednesday, 06'th May 2020
PALO ALTO, Calif., May 06, 2020 -- BridgeBio Pharma, Inc. (Nasdaq: BBIO) announced today that it will present at the Bank of America Securities 2020 Health Care Conference on.
Adopt Cobra For Rs 2,000 A Year, Elephant For Rs 1.75 Lakh At Bengaluru Zoo
06:53pm, Friday, 01'st May 2020
Wish to adopt an Indian cobra for as low as Rs 2,000 per annum or Asiatic elephant for Rs 1.75 lakh?
What will the Oracle say?
09:05am, Friday, 01'st May 2020
News is free at Seeking Alpha.This post is a Notable Call. Notable Calls are a Premium feature.To access this and other Notable Calls, try a free trial to Seeking Alpha Premium.
BridgeBio's Pipeline Expansion Continues as Portfolio's Milestones Approach
02:00pm, Thursday, 30'th Apr 2020
BridgeBio Pharma Inc. is poised to achieve its goal of rapidly bringing treatments for genetic diseases and genetically defined cancers to the market with
The cheapest and best value hoverboards you can buy in 2020
08:00am, Thursday, 16'th Apr 2020
LOOKING for a slice of the future? Grab yourself one of these great value hoverboards and you’ll be gliding around effortlessly on your own personal transport. 2020’s best hoverboards are a relati
Andreas Halvorsen Checks Into Zentalis Pharmaceuticals
08:47pm, Wednesday, 15'th Apr 2020
Viking Partners leader makes real-time pick in biotech IPO Continue reading...
Andreas Halvorsen Checks Into Zentalis Pharmaceuticals
08:18pm, Wednesday, 15'th Apr 2020
Andreas Halvorsen Checks Into Zentalis Pharmaceuticals, Stocks: ZNTL,ADPT,ANTM,BBIO,BSX, Andreas Halvorsen, release date:Apr 15, 2020
Sign In
Buy BBIO